(NASDAQ: PROF) Profound Medical's forecast annual revenue growth rate of 86.9% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Profound Medical's revenue in 2025 is $8,254,347.On average, 3 Wall Street analysts forecast PROF's revenue for 2025 to be $533,533,430, with the lowest PROF revenue forecast at $518,717,231, and the highest PROF revenue forecast at $546,967,184. On average, 3 Wall Street analysts forecast PROF's revenue for 2026 to be $984,240,401, with the lowest PROF revenue forecast at $973,721,801, and the highest PROF revenue forecast at $1,000,769,629.
In 2027, PROF is forecast to generate $1,656,619,346 in revenue, with the lowest revenue forecast at $1,499,651,786 and the highest revenue forecast at $1,907,472,923.